Diagnostics

#Business #Diagnostics #Life sciences

PerkinElmer focuses on life sciences in $2.45bn deal

Life sciences company PerkinElmer will divest its Applied, Food and Enterprise Services to the private equity firm New Mountain Capital in a potential deal worth $2.45 billion. PerkinElmer states that the deal comes at a pivotal moment for the company as it transitions to solely focusing on its Life… Read More

#News

#Diagnostics #Neurology #Oncology

Research paves way for easier brain tumour diagnosis  

New research could pave the way to the earlier diagnosis of brain tumours through the development of a simple blood test for glioblastomas.  Researchers from the University of Bristol in the UK, developed mathematical models to assess the current use of biomarkers in the detection of glioblastomas… Read More

#News

#Antibody drug conjugate (ADC) #Diagnostics #Oncology

This week in drug discovery (13-17 June)

News round-up by DDW’s Reece Armstrong for 13-17 June. Partnerships, awards, and new companies are some of the topics of this week’s news round-up. Bachem & Eli Lilly partner on oligonucleotide project Swiss pharmaceutical company Bachem has partnered with Eli Lilly on a seven-year agreement to advance the development of… Read More

#News

#Covid-19 #Diagnostics #Manufacturing

GADx launches as social enterprise for diagnostics  

Diagnostics company Mologic and its sister company Global Access Diagnostics (GAD) have combined their expertise to form a new business aimed at addressing the gaps in the provision of diagnostics, with a focus on expanding affordable access to quality tests.  Global Access Diagnostics (GADx) is the first… Read More

#News

#Diagnostics #Genetics / genomes #Rare disease

PacBio and Children’s Mercy expand genetic research collaboration 

PacBio has expanded a research collaboration with Children’s Mercy Kansas City in an effort to improve scientists’ understanding of the genetic underpinnings of rare diseases.   The collaboration will see Children’s Mercy Kansas City use the multi-omics capabilities of PacBio’s Sequel IIe system in the study of genetic… Read More

#News

#Diagnostics #MedCity

London diagnostics boosted in R&D collaboration project

A group of London-based diagnostic healthcare SMEs has been awarded match-funded research partnerships to help advance its disease identifying technologies.  The partnerships are being mediated by London’s life sciences cluster organisation, MedCity, as part of its Collaborate to Innovate: London Diagnostics programme. Through the programme, the companies… Read More

#News

#Covid-19 #Diagnostics #PCR #Screening

App note: SARS-CoV-2 detection workflow in wastewater

Monitoring wastewater for SARS-CoV-2 – or Coronavirus as it is more commonly known – can be a valuable data resource for an effective Covid-19 management. However, there are several challenges involved in detecting biological parameters in wastewater. Fortunately, there are also several solutions available to overcome them. Wastewater can be… Read More

#News

#Cancer research #Diagnostics #Drug innovation #Healthcare

Collaboration to produce an ADC to treat neuroendocrine cancers 

Novasep, a supplier of services and technologies for the life sciences industry, and McSAF, a French biotech specialised in bioconjugation tools to design bio drugs for health and diagnostics, have collaborated for the preclinical production of ADCITMER, a next-generation Antibody-Drug Conjugate (ADC) to treat neuroendocrine cancers.   What has been done?… Read More

#News

#Diagnostics #Events #SLAS 2021

Who is delivering the keynote presentations for SLAS Europe 2021?

The schedule of the upcoming SLAS Europe 2021 Conference & Exhibition from June 23-25 is available to view and registration remains open. Keynote presentations include the opening presentation with Professor Johannes Grillari, Director of the Ludwig Boltzmann Institute for Experimental and Clinical Traumatology. He will cover: ‘From Cellular… Read More

#News

#Biotechnology #Diagnostics #Drug discovery #Immunology #Immunology / Virology & Vaccines #Pandemic

University of Oxford to launch Pandemic Sciences Centre

The University of Oxford has announced the launch of a new centre of global research collaboration and excellence, the Pandemic Sciences Centre. Its mission will be to ensure that the world is better equipped to create global, and equitable science-driven solutions to prepare for, identify, and counter future pandemic threats. Read More

#News #Trending News

#Cancer research #Diagnostics #Drug development #In vitro

Avacta enters diagnostic licensing deal with Biokit

Avacta, developer of cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms, has announced a licensing agreement with Biokit, to incorporate Affimer reagents into a Biokit in-vitro diagnostic (IVD) product. Biokit has experience in research, development and manufacturing of assays and biomaterial solutions for IVD use. Under… Read More

#Cancer Research #News

#Diagnostics #Drug development #Drug discovery #Webinar

Why hepatocytes are enabling antimalarial drug discovery

BioIVT, providers of research models and services for drug and diagnostic development, will be hosting a webinar where researchers from the University of Georgia will explain the first medium-throughput, 384-well plate-based liver-stage antimalarial drug discovery platform which they have developed. The webinar, entitled Identifying the Critical Factors Enabling a Phenotypic… Read More

#News

#Covid-19 #Diagnostics #Drug development

BioIVT unveils COVID-19 panel to boost vaccine-generated immune response research

BioIVT, provider of research models and services for drug and diagnostic development, has introduced its COVID-19 Vaccination Panel, composed of pre- and post-vaccination serum or PBMC samples, to enable researchers to study blood donors’ vaccine-generated immune response. BioIVT has been providing more than 300 clients with biospecimens to support the… Read More

#Covid-19 #Editor's Choice #News

#Covid-19 #CRISPR #Diagnostics

Mammoth Biosciences and Agilent partner on CRISPR-based SARS-CoV-2 diagnostic

Mammoth Biosciences has announced an agreement with Agilent Technologies to support the anticipated launch of a complete CRISPR-based SARS-CoV-2 diagnostic solution comprising Agilent’s Bravo automation workstation and Mammoth Biosciences’ DETECTR BOOSTTM assay. Together, the DETECTR BOOSTTM SARS-CoV-2 kit and Agilent automated liquid handling system would provide a complete workflow for… Read More

#Covid-19 #News

#Assay development & optimisation #Biomarkers #Diagnostics #In vitro

BioIVT to host emerging technologies in diagnostics symposium

BioIVT will be hosting a virtual Emerging Technologies in Diagnostics Symposium on  Thursday, October 29 (10am-1pm ET). “The diagnostic assay landscape is changing rapidly as the demand for faster, less expensive, more precise diagnostics continues to grow,” said Cathie Miller, Director of Product Marketing, Personalised Medicine at BioIVT. “We wanted… Read More

#News